Access the full text.
Sign up today, get DeepDyve free for 14 days.
O. Valverde, E. Tzavara, J. Hanoune, B. Roques, R. Maldonado (1996)
Protein Kinases in the Rat Nucleus Accumbens are Involved in the Aversive Component of Opiate WithdrawalEuropean Journal of Neuroscience, 8
D. Moss, G. Koob, S. Mcmaster, D. Janowsky (1984)
Comparative effects of tetrahydrocannabinol on psychostimulant-induced behaviorsPharmacology Biochemistry and Behavior, 21
G. Chiara, R. North (1992)
Neurobiology of opiate abuse.Trends in pharmacological sciences, 13 5
J. Manzanares, J. Corchero, J. Romero, J. Fernández-Ruiz, J. Ramos, J. Fuentes (1999)
Pharmacological and biochemical interactions between opioids and cannabinoids.Trends in pharmacological sciences, 20 7
S. Childers, L. Fleming, C. Konkoy, Don Marckel, M. Pacheco, T. Sexton, S. Ward (1992)
Opioid and Cannabinoid Receptor Inhibition of Adenylyl Cyclase in Brain aAnnals of the New York Academy of Sciences, 654
W. Dewey, L. Harris, J. Howes, J. Kennedy, F. Granchelli, H. Pars, R. Razdan (1970)
Pharmacology of some Marijuana Constituents and Two Heterocyclic AnaloguesNature, 226
R. Gerlai (1996)
Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?Trends in Neurosciences, 19
E. Valjent, Rafael Maldonado (2000)
A behavioural model to reveal place preference to Δ9-tetrahydrocannabinol in micePsychopharmacology, 147
B. Hine, E. Friedman, M. Torrelio, S. Gershon (1975)
Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol.Science, 187 4175
Koob (1998)
Neuroscience of addictionNeuron, 21
O. Valverde, C. Ledent, F. Beslot, M. Parmentier, B. Roques (2000)
Reduction of stress‐induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptorsEuropean Journal of Neuroscience, 12
P. Mailleux, J. Vanderhaeghen (1992)
Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistryNeuroscience, 48
C. Ledent, O. Valverde, G. Cossu, F. Petitet, J. Aubert, F. Beslot, G. Böhme, A. Imperato, T. Pedrazzini, B. Roques, G. Vassart, W. Fratta, M. Parmentier (1999)
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.Science, 283 5400
G. Tanda, F. Pontieri, G. Chiara (1997)
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.Science, 276 5321
M. Lepore, Stanislav Vorel, J. Lowinson, E. Gardner (1995)
Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward.Life sciences, 56 23-24
A. Howlett, R. Fleming (1984)
Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes.Molecular pharmacology, 26 3
J. Romero, R. Miguel, J. Ramos, J. Fernández-Ruiz (1997)
The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake.Life sciences, 62 4
J. Delfs, Yan Zhu, J. Druhan, G. Aston-Jones (2000)
Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversionNature, 403
M. Bidaut‐Russell, Allyn Hewlett (1991)
Cannabinoid Receptor‐Regulated Cyclic AMP Accumulation in the Rat StriatumJournal of Neurochemistry, 57
M. Bouaboula, C. Poinot-Chazel, B. Bourrie, X. Canat, B. Calandra, M. Rinaldi-Carmona, G. Fur, P. Casellas (1995)
Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.The Biochemical journal, 312 ( Pt 2)
M. Mascia, M. Obinu, C. Ledent, Marc Parmentier, G. Böhme, Assunta Imperato, Walter Fratta (1999)
Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice.European journal of pharmacology, 383 3
A. Zimmer, A. Zimmer, A. Hohmann, M. Herkenham, T. Bonner (1999)
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.Proceedings of the National Academy of Sciences of the United States of America, 96 10
F. Fonseca, M. Carrera, M. Navarro, G. Koob, F. Weiss (1997)
Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal.Science, 276 5321
T. Shippenberg, C. Heidbreder (1995)
Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics.The Journal of pharmacology and experimental therapeutics, 273 2
G. Koob (1992)
Neural Mechanisms of Drug Reinforcement aAnnals of the New York Academy of Sciences, 654
G. Koob, M. Moal (1997)
Drug abuse: hedonic homeostatic dysregulation.Science, 278 5335
I. Reche, J. Fuentes, M. Ruiz‐Gayo (1996)
Potentiation of Δ9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of μ- and κ-opioid receptorsEuropean Journal of Pharmacology, 318
T. Shippenberg, C. Heidbreder, A. Lefevour (1996)
Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics.European journal of pharmacology, 299 1-3
F. Simonin, O. Valverde, C. Smadja, S. Slowe, I. Kitchen, A. Dierich, M. Meur, B. Roques, R. Maldonado, B. Kieffer (1998)
Disruption of the κ‐opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ‐agonist U‐50,488H and attenuates morphine withdrawalThe EMBO Journal, 17
A. Lichtman, Billy Martin (1991)
Spinal and supraspinal components of cannabinoid-induced antinociception.The Journal of pharmacology and experimental therapeutics, 258 2
G. Pryor, F. Larsen, S. Husain, M. Braude (1978)
Interactions of Δ 9-tetrahydrocannabinol with d-Amphetamine, cocaine, and nicotine in ratsPharmacology Biochemistry and Behavior, 8
Nestler (1992)
Molecular mechanisms of drug addictionJ. Neurosci, 12
T. Vries, A. Schoffelmeer, R. Binnekade, A. Mulder, L. Vanderschuren (1998)
Drug‐induced reinstatement of heroin‐ and cocaine‐seeking behaviour following long‐term extinction is associated with expression of behavioural sensitizationEuropean Journal of Neuroscience, 10
R. Maldonado, Adolfo Saiardi, O. Valverde, T. Samad, B. Roques, E. Borrelli (1997)
Absence of opiate rewarding effects in mice lacking dopamine D2 receptorsNature, 388
M. Navarro, J. Chowen, M. Carrera, I. Arco, M. Villanúa, Yolanda Martin, A. Roberts, G. Koob, F. Fonseca (1998)
CB1 cannabinoid receptor antagonist‐induced opiate withdrawal in morphine‐dependent ratsNeuroReport, 9
L. Stinus, M. Moal, G. Koob (1990)
Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawalNeuroscience, 37
L. Vanderschuren, E. Schmidt, T. Vries, Caroline Moorsel, F. Tilders, A. Schoffelmeer (1999)
A Single Exposure to Amphetamine Is Sufficient to Induce Long-Term Behavioral, Neuroendocrine, and Neurochemical Sensitization in RatsThe Journal of Neuroscience, 19
Hattendorf (1977)
Interaction of Δ9-tetrahydrocannabinol and d-anphetaminePsychopharmacology, 54
M. Gorriti, F. Fonseca, M. Navarro, T. Palomo (1999)
Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats.European journal of pharmacology, 365 2-3
A. Howlett (1985)
Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes.Molecular pharmacology, 27 4
R. Maldonado, O. Valverde, B. Ducos, A. Blommaert, M. Fournie-Zaluski, B. Roques (1995)
Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD‐134,308British Journal of Pharmacology, 114
The involvement of cannabinoid CB1 receptors in morphine and cocaine motivational effects was investigated using CB1 knockout mice. For this purpose, we evaluated the rewarding effects in the place conditioning paradigm and the sensitization to the locomotor responses induced by these drugs. The hyperlocomotion induced by acute morphine administration (15 mg/kg, s.c.) was preserved, but the sensitization to this locomotor response induced by chronic morphine treatment was abolished in CB1 mutant mice. Morphine (5 mg/kg, s.c.) induced conditioned place preference in wild‐type mice but failed to produce any response in knockout mice, indicating the inability of morphine to induce rewarding effects in the absence of CB1 cannabinoid receptors. When the aversive effects of morphine withdrawal were investigated using the place aversion paradigm, no differences between genotypes were observed. Acute cocaine (10 mg/kg, i.p.) induced hyperlocomotor responses in wild‐type and knockout mice and a chronic cocaine treatment produced a similar sensitization to this response in both genotypes. In the conditioning place preference paradigm, cocaine (20 mg/kg, i.p.) produced rewarding responses in both wild‐type and knockout mice. These results demonstrate that CB1 receptors are essential for adaptive responses produced by chronic morphine but not by chronic cocaine treatment.
European Journal of Neuroscience – Wiley
Published: Nov 1, 2000
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.